In conclusion, the characteristics of combined obesity, impaired glucose tolerance and hypercholesterolemia in the DIO-hamster make this animal model useful for preclinical evaluation of novel anti-obesity, insulin sensitizing, and lipid modulating agents. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.